Akelos Inc. Identifies Key Aspects Governing Pharmacophore Interactions With Target Site

Source :: Plus Company Updates. February 26, 2019
Publication Year :: 2019
Abstract: NEW YORK: Akelos Inc. has issued the following press release: Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic pain, [...]

Subjects :: Pain management
Alkylphenols
General interest
News, opinion and commentary

Tools